ChenGuang Biotech Group Co., Ltd.

300138

CNE100000WC5

Food Processing

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-17 pm EDT			5-day change	1st Jan Change
9.3 ^CNY	-2.82%		-8.28%	-30.75%

Apr. 03	Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.	CI
Feb. 01	ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Chenguang Biotech Says Unit Plans Listing in China's Third Board

October 08, 2021 at 08:45 am EDT

ChenGuang Biotech Group Co., Ltd. (SZSE:300138) said its unit plans listing in china's National Equities Exchange and Quotations (NEEQ).

Latest news about ChenGuang Biotech Group Co., Ltd.

Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.	Apr. 02	CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 01	CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback.	Jan. 31	CI
Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.	Jan. 02	CI
ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback.	Dec. 20	CI
ChenGuang Biotech Group Co., Ltd. commences an Equity Buyback Plan for CNY 100 million worth of its shares, under the authorization approved on November 17, 2023.	Nov. 20	CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-23	CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-13	CI
US targets two China-based firms over forced labor practices -DHS	23-08-01	RE
Chenguang Biotech Group Co., Ltd. Announces Management Appointment	23-05-30	CI
ChenGuang Biotech Group Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 17 May 2023	23-05-10	CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-25	CI
ChenGuang Biotech Group Co., Ltd. Approves Cash Dividend for the Year 2022	23-04-20	CI
ChenGuang Biotech Group Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-03-27	CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-28	CI
Chenguang Biotech Sees 28% Rise in FY'22 Profit	23-01-16	MT
Wang Guangming signed the share transfer agreement to acquire 4.27% stake in Qingdao Spicy Workshop Food Co., Ltd. for 12.40 million.	22-12-13	CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-22	CI
Liu Yingshan signed Equity Transfer Agreement to acquire Xinjiang Tianjiao Hongan Agricultural Technology Co., Ltd. from ChenGuang Biotech Group Co., Ltd. and Xinjiang Chenxi Pepper Industry Co., Ltd. for CNY 88.3 million.	22-06-01	CI
Chenguang Biotech Group Co., Ltd. Announces 2021 Final Cash Dividend Proposal on A Shares, Payable on 1 June 2022	22-05-25	CI
UBS Adjusts ChenGuang Biotech’s Price Target to 21.50 Yuan From 20.80 Yuan, Keeps at Buy	22-04-27	MT
ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-25	CI
Chenguang Biotech Group Co., Ltd. Approves Cash Dividend	22-04-20	CI
UBS Adjusts Chenguang Biotech Group's Price Target to 20.8 Yuan From 19, Keeps at Buy	22-03-30	MT

Chart ChenGuang Biotech Group Co., Ltd.

Duration

Period

More charts

Chenguang Biotech Group Co., Ltd. is a China-based company principally engaged in the manufacture and sales of natural pigment extracts, natural spices extracts, essential oil extracts, natural supplement and medicine extracts, fat and protein and others. The Companyâs products include pigment, spices, supplement and medicine products, cottonseed products and others. The Company distributes its products in domestic and to overseas markets.

Sector

Food Processing

Calendar

2024-04-24 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for ChenGuang Biotech Group Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

9.3 CNY

Average target price

17.66 CNY

Spread / Average Target

+89.87%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Food Processing

	1st Jan change	Capi.
CHENGUANG BIOTECH GROUP CO., LTD.	-30.75%	685M
NESTLÉ S.A.	-3.48%	268B
MONDELEZ INTERNATIONAL, INC.	-7.26%	90.35B
KRAFT HEINZ	+0.35%	45.11B
DANONE	+1.02%	40.42B
GENERAL MILLS, INC.	+6.06%	39B
THE HERSHEY COMPANY	-0.85%	37.75B
ARCHER-DANIELS-MIDLAND COMPANY	-14.54%	30.97B
NESTLÉ INDIA LIMITED	-8.36%	28.41B
YIHAI KERRY ARAWANA HOLDINGS CO., LTD	-9.38%	22.66B

Other Food Processing